Newbury Pharmaceuticals AB
Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.
Newbury Pharmaceuticals AB (NEWBRY) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of November 2025: -0.183x
Based on the latest financial reports, Newbury Pharmaceuticals AB (NEWBRY) has a cash flow conversion efficiency ratio of -0.183x as of November 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-6.55 Million) by net assets (Skr35.85 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Newbury Pharmaceuticals AB - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Newbury Pharmaceuticals AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Newbury Pharmaceuticals AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Newbury Pharmaceuticals AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
STERICYCLE
MU:SY9
|
0.026x |
|
SRIVARU Holding Limited Warrant
NASDAQ:SVMHW
|
N/A |
|
Rainmaker Worldwide Inc
PINK:RAKR
|
0.001x |
|
Alelion Energy Systems AB
ST:ALELIO
|
1.501x |
|
Augwind Energy Tech Storage Ltd
TA:AUGN
|
-0.071x |
|
GLG Corp Ltd
AU:GLE
|
-0.053x |
|
Dominion Income Trust 1
AU:DN1
|
N/A |
|
FIRST SENSOR
BE:SIS
|
-0.021x |
Annual Cash Flow Conversion Efficiency for Newbury Pharmaceuticals AB (2021–2024)
The table below shows the annual cash flow conversion efficiency of Newbury Pharmaceuticals AB from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-08-31 | Skr51.92 Million | Skr-23.71 Million | -0.457x | +2.92% |
| 2023-08-31 | Skr49.38 Million | Skr-23.23 Million | -0.470x | -115.64% |
| 2022-08-31 | Skr68.77 Million | Skr-15.00 Million | -0.218x | -106.38% |
| 2021-08-31 | Skr38.47 Million | Skr-4.07 Million | -0.106x | -- |